IDEX said net sales for Q1 2025 rose 2% to $814.3 million, while organic sales fell 1%, and net income attributable to IDEX fell to $95.5 million from $121.4 million a year earlier.

1. 01

   IDEX said net sales for Q1 2025 rose 2% to $814.3 million, while organic sales fell 1%, and net income attributable to IDEX fell to $95.5 million from $121.4 million a year earlier.

2. 02

   The company said diluted EPS for Q1 was $1.26 ($1.60 a year earlier) and adjusted diluted EPS was $1.75 ($1.88 a year earlier), with adjusted EBITDA of $208.0 million and an adjusted EBITDA margin of 25.5%.

3. 03

   Cash flow from operations for Q1 was $105.7 million ($156.6 million a year earlier), and free cash flow was $91.4 million ($136.6 million a year earlier), the company said. It cited higher inventory build and interest payments on senior notes as factors that reduced cash flow.

4. 04

   IDEX said it expects GAAP diluted EPS for 2025 of $6.56 to $6.95 (adjusted $8.10 to $8.45) and organic sales growth of 1% to 3%. It also cited an additional $20 million of cost containment actions.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.